ENHANCING ANTI-CTLA4 IMMUNOLOGY THERAPY FOR PROSTATE CANCER WITH COTARGETING SOLUBLE NKG2D LIGAND

$560,625FY2015Department of the ArmyDOD

The Medical University Of South Carolina

Investigators